MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
MCB Accepts, published online ahead of print on 22 January 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
MCB.01977-07v1
28/7/2167    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ivanovska, I.
Right arrow Articles by Cleary, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ivanovska, I.
Right arrow Articles by Cleary, M. A.

 Previous Article  |  Next Article 

Mol. Cell. Biol. doi:10.1128/MCB.01977-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression

Irena Ivanovska*, Alexey S. Ball, Robert L. Diaz, Jill F. Magnus, Miho Kibukawa, Janell M. Schelter, Sumire V. Kobayashi, Lee Lim, Julja Burchard, Aimee L. Jackson, Peter S. Linsley, and Michele A. Cleary

Rosetta Inpharmatics, LLC, a wholly owned subsidiary of Merck and Co. Inc., Seattle, WA 98109

* To whom correspondence should be addressed. Email: irena_ivanovska{at}merck.com.


   Abstract

microRNAs in the miR-106b family are over-expressed in multiple tumor types and are correlated with the expression of genes that regulate the cell cycle. Consistent with these observations, miR-106b family gain-of-function promotes cell-cycle progression, whereas loss-of-function reverses this phenotype. Microarray profiling uncovers multiple targets of the family including the cyclin-dependent kinase inhibitor p21/CDKN1A. We show that p21 is a direct target of miR-106b and its silencing plays a key role in miR-106b-induced cell-cycle phenotypes. We also show that miR-106b overrides a doxorubicin-induced DNA damage checkpoint. Thus, miR-106b family members contribute to tumor cell proliferation in part by regulating cell cycle progression and by modulating checkpoint functions.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.